Respiratory Infections, Acute Recruiting Phase 3 Trials for Ingavirin (DB11944)

Also known as: Acute Respiratory Infections (ARIs) / Acute Infection Respiratory / Acute Respiratory Infections / Acute Respiratory Infection

IndicationStatusPhase
DBCOND0031056 (Respiratory Infections, Acute)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05269290Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral InfectionsTreatment